For example, oral cancer cells often have specific molecular markers, such as EGFR (Epidermal Growth Factor Receptor) or human papillomavirus-associated markers, and targeted therapies can selectively target these markers to inhibit cancer cell growth while protecting normal cells [111,112]. The gene discussed is EGFR; the disease is cancer.